People-search and data-broker listings

Evaluate a known listing against the source’s opt-out process.

A source-specific pathway for people-search and data-broker listings. It distinguishes a documented opt-out request from source removal, search visibility, or unrelated copies elsewhere.

A pathway is not a promise.

The route is evaluated from the facts and sources you supply. Source, search, and platform decisions remain outside the platform’s control.

Evidence readiness

What helps a review begin well.

You do not need to tell a full story at entry. These are examples of helpful materials for a specialist to classify a known item and explain the route responsibly.

  • The exact people-search or data-broker profile URL and source name.
  • The specific field or listing information to be evaluated.
  • Any source-provided opt-out reference, account instruction, or prior response.
  • A dated observation record, while avoiding upload of unnecessary identity documents until a source-specific requirement is reviewed.

Possible route outputs

Classified before it is represented as resolved.

01

Data-broker opt-out review for the named source and listing.

02

Privacy-rights or source-policy review where a different route is supported.

03

Search de-indexing review when a named result requires a distinct search-context assessment.

04

Monitoring of the agreed source/listing scope after a verified observation.

Non-coverage is part of the decision

The boundaries are visible before you proceed.

One broker’s listing is not evidence that all brokers, archives, or search results will change.
Some sources require verification, retain certain records, or republish from later data feeds; no source action is guaranteed.
A source-level opt-out is not represented as de-indexing or removal from other sources.
A new listing, changed URL, or different broker is a separate scope unless explicitly included.

Private next step

See the route for sources you already know.

Begin a private Exposure Map with the known profile source. The assessment keeps the first intake limited and identifies what the relevant opt-out route may require.

Content last reviewed: August 2026. This page provides pathway information, not legal advice.

All pathways